David S. Grayzel, Director at Aerovate Therapeutics, Inc. (AVTE), bought 3,103,879 shares at $14.00 ($7.5M) on 2021-07-02, disclosed to the SEC on 2021-07-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,568,165 | $0 | 0.0% |
| 2 | $14.00 | 535,714 | $7.5M | 100.0% |
| Total | $2.42 avg | 3,103,879 | $7.5M | 100% |
| Filing → |
| SURF | SELL | 2020-12-21 | $13.8M | — | Filing → |
| SURF | BUY | 2018-04-23 | $1.5M | — | Filing → |